Cargando…

LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma

Bladder cancer (BC) is the most lethal malignant cancer of the genitourinary system, and bladder urothelial carcinoma (BUC) is the most common type of BC. The long non-coding RNA (lncRNA) plasmacytoma variant translocation 1 (PVT1) is overexpressed in several malignant tumors, including BC. Using a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhongyuan, Zhang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610001/ https://www.ncbi.nlm.nih.gov/pubmed/28969069 http://dx.doi.org/10.18632/oncotarget.19604

Ejemplares similares

Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer
por: Li, Bin, et al.
Publicado: (2020)

Regulation mechanism and pathogenic role of lncRNA plasmacytoma variant translocation 1 (PVT1) in human diseases
por: Wu, Fang, et al.
Publicado: (2022)

A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma
por: Bao, Zhenyu, et al.
Publicado: (2017)

Long non-coding RNA (lncRNA) plasmacytoma variant translocation 1 gene (PVT1) modulates the proliferation and apoptosis of acute lymphoblastic leukemia cells by sponging miR-486-5p
por: Ju, Jin-Ke, et al.
Publicado: (2022)

LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma
por: Li, Chunjing, et al.
Publicado: (2020)

Bladder extramedullary plasmacytoma and synchronous bladder urothelial transitional cell carcinoma: A case report and review of the literature
por: Wadhwa, Karan, et al.
Publicado: (2011)

FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma
por: Quan, Lian-Jiao, et al.
Publicado: (2019)

Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022)

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Oncogenic roles of the lncRNA LINC00460 in human cancers
por: Su, Min, et al.
Publicado: (2022)

Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder
por: Sun, Zhulei, et al.
Publicado: (2019)

Knockdown of lncRNA HNF1A-AS1 inhibits oncogenic phenotypes in colorectal carcinoma
por: Zhu, Wenyi, et al.
Publicado: (2017)

Knockdown of lncRNA HNF1A-AS1 inhibits oncogenic phenotypes in colorectal carcinoma
por: Zhu, Wenyi, et al.
Publicado: (2019)

LncRNA-RMRP Acts as an Oncogene in Lung Cancer
por: Meng, Qingjun, et al.
Publicado: (2016)

A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma
por: Hou, Jian, et al.
Publicado: (2022)

Long non-coding RNA LINC00336 as an independent prognostic indicator and an oncogenic lncRNA in bladder cancer
por: Guo, Xi, et al.
Publicado: (2019)

Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer
por: Wu, Huijie, et al.
Publicado: (2021)

Comprehensive investigation of the clinical significance and molecular mechanisms of plasmacytoma variant translocation 1 in sarcoma using genome-wide RNA sequencing data
por: Liu, Jianwei, et al.
Publicado: (2019)

lncRNA PVT1: a novel oncogene in multiple cancers
por: Li, Ruiming, et al.
Publicado: (2022)

Long noncoding RNA plasmacytoma variant translocation gene 1 promotes epithelial‐mesenchymal transition in osteosarcoma
por: Xun, Chuanhui, et al.
Publicado: (2020)

The association between polymorphism of the long noncoding RNA, Plasmacytoma variant translocation 1, and the risk of gastric cancer
por: Park, Jae Ho, et al.
Publicado: (2021)

Salvianolic Acid A Protects H9C2 Cardiomyocytes from Doxorubicin-Induced Damage by Inhibiting NFKB1 Expression Thereby Downregulating Long-Noncoding RNA (lncRNA) Plasmacytoma Variant Translocation 1 (PVT1)
por: Wu, Yumeng, et al.
Publicado: (2021)

Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer
por: Chen, Mingwei, et al.
Publicado: (2017)

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
por: Wang, Dejie, et al.
Publicado: (2015)

Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma
por: Wang, Yiru, et al.
Publicado: (2022)

Functional Characterization of the Plasmacytoma Variant Translocation 1 Gene (PVT1) in Diabetic Nephropathy
por: Alvarez, M. Lucrecia, et al.
Publicado: (2011)

Genetic variants of lncRNA HOTAIR contribute to the risk of osteosarcoma
por: Zhou, Quan, et al.
Publicado: (2016)

Genetic variants in lncRNA SRA and risk of breast cancer
por: Yan, Rui, et al.
Publicado: (2016)

LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma: retraction
por: Li, Chunjing, et al.
Publicado: (2023)

Nested variant of urothelial carcinoma of the urinary bladder
por: Terada, Tadashi
Publicado: (2011)

The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma
por: Chen, Shuo, et al.
Publicado: (2017)

Long Noncoding RNA Plasmacytoma Variant Translocation 1 Is Increased in Multiple Myeloma and Correlates With Lower Induction Response
por: Li, Pei, et al.
Publicado: (2020)

LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer
por: Xiong, Tiefu, et al.
Publicado: (2020)

LncRNA EIF3J-AS1 functions as an oncogene by regulating MAFG to promote prostate cancer progression
por: Ye, Chen, et al.
Publicado: (2022)

Long non-coding RNA plasmacytoma variant translocation 1 and growth arrest specific 5 regulate each other in osteoarthritis to regulate the apoptosis of chondrocytes
por: Cai, Liquan, et al.
Publicado: (2022)

Circular RNA Plasmacytoma Variant Translocation 1 (CircPVT1) knockdown ameliorates hypoxia-induced bladder fibrosis by regulating the miR-203/Suppressor of Cytokine Signaling 3 (SOCS3) signaling axis
por: Li, Teng, et al.
Publicado: (2022)

LncRNA FOXD1‐AS1 acts as a potential oncogenic biomarker in glioma
por: Gao, Yuan‐Feng, et al.
Publicado: (2019)

Differential Expression of LncRNA in Bladder Cancer Development
por: Spirito, Lorenzo, et al.
Publicado: (2023)

lncRNA-mediated ceRNA network in bladder cancer
por: Li, Kun, et al.
Publicado: (2022)

lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression
por: Yang, Tao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dq7upctq9bov1ovje449k95und